Eight specimens – collected over six days – are examined for levels of estradiol, estrone, estriol, progesterone, the progesterone/estradiol ratio (P/E2), and testosterone. In addition to thorough evaluation of the sex hormones, Menopause Plus also evaluates DHEA, cortisol, and melatonin for the broadest scope of clinical insight. To enhance clinical utility, in addition to evaluating patient results against various healthy cohort reference ranges, a therapeutic cohort results cover page is provided for the clinician to quickly and conveniently observe where patient results fall in comparison to a cohort of peri/menopausal women treated with bioidentical hormone therapy. The Menopause Plus hormone test provides information about the impact that shifting hormone levels can have in women during perimenopause and menopause and in men during andropause (male menopause). In addition, imbalances of other steroid hormones, such as DHEA, cortisol, and melatonin, can influence sex-hormone production. Additional Biomarkers Available for add-on at additional cost: Cortisol Awakening Response Analytes Reported: Cortisol DHEA Estradiol Estriol Estrone Melatonin Progesterone Testosterone